EUVIMEDEUVIMED entdecken
Crossref

In silico ADMET: Supporting new drug discovery

Sagar Agrawal, Pragya Pandey, Anie Jacob, Vishal Tiwari, Rakesh Kumar Dixit, Rahul Kumar

Future Health · 14.04.2026 · 4 · 49-56

DOI: 10.25259/fh_100_2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Health, online erschienen am 14.04.2026. Verfasst von Sagar Agrawal und 5 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties are major determinants of drug success, accounting for nearly half of late-stage clinical attrition. In silico ADMET prediction tools offer a rapid, cost-effective, and animal-free strategy for early-stage screening, enabling the evaluation of hundreds to thousands of compounds prior to synthesis or in vivo testing. This review summarizes current in silico ADMET approaches, ranging from rule-based filters and QSAR models to advanced artificial intelligence (AI) and machine-learning platforms, and compares widely used tools such as SwissADME, pkCSM, and ADMETlab 3.0. AI-based ADMET models provide a clear advantage by supporting multi-endpoint prediction, high-throughput screening, and improved prioritization of lead compounds, thereby reducing experimental burden and development timelines. However, their predictive performance remains constrained by training-data bias, limited applicability domains, and reduced interpretability, necessitating experimental validation and cautious regulatory use. Overall, in silico ADMET prediction represents a transformative yet complementary component of modern drug discovery pipelines rather than a standalone replacement for experimental assessment.

Zitieren

APA

Agrawal, S., Pandey, P., Jacob, A., Tiwari, V., Dixit, R. K., & Kumar, R. (2026). In silico ADMET: Supporting new drug discovery. Future Health, 4, 49-56. https://doi.org/10.25259/fh_100_2025

Vancouver

Agrawal S, Pandey P, Jacob A, Tiwari V, Dixit RK, Kumar R. In silico ADMET: Supporting new drug discovery. Future Health. 2026;4:49-56. doi:10.25259/fh_100_2025

BibTeX
@article{Agrawal2026,
  author = {Agrawal, Sagar and Pandey, Pragya and Jacob, Anie and Tiwari, Vishal and Dixit, Rakesh Kumar and Kumar, Rahul},
  title = {In silico ADMET: Supporting new drug discovery},
  journal = {Future Health},
  year = {2026},
  volume = {4},
  pages = {49--56},
  doi = {10.25259/fh_100_2025}
}
Kostenlos starten →